Post-approval studies (Phase 4)Study completedNCT03341429
What this trial is testing
Evaluation of Liraglutide 3.0mg in Patients With Poor Weight-loss and a Suboptimal Glucagon-like Peptide-1 Response
Who this might be right for
Obesity
University College, London 70